Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation
In inflammation, extensive cell death may occur, which results in the release of chromatin
components into the extracellular environment. Individually, the purified chromatin …
components into the extracellular environment. Individually, the purified chromatin …
Extracellular DNA and histones: double‐edged swords in immunothrombosis
TJ Gould, Z Lysov, PC Liaw - Journal of Thrombosis and …, 2015 - Wiley Online Library
The existence of extracellular DNA in human plasma, also known as cell‐free DNA (cf DNA),
was first described in the 1940s. In recent years, there has been a resurgence of interest in …
was first described in the 1940s. In recent years, there has been a resurgence of interest in …
MicroRNAs are exported from malignant cells in customized particles
J Palma, SC Yaddanapudi, L Pigati… - Nucleic acids …, 2012 - academic.oup.com
MicroRNAs (miRNAs) are released from cells in association with proteins or microvesicles.
We previously reported that malignant transformation changes the assortment of released …
We previously reported that malignant transformation changes the assortment of released …
Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer
TJ Shaw, MK Senterman, K Dawson, CA Crane… - Molecular therapy, 2004 - cell.com
Improvement of ovarian cancer patient outcome requires well-characterized animal models
in which to evaluate novel therapeutics. Xenograft models are frequently used, but with little …
in which to evaluate novel therapeutics. Xenograft models are frequently used, but with little …
Epigenetics of cervical cancer. An overview and therapeutic perspectives
A Dueñas-González, M Lizano, M Candelaria, L Cetina… - Molecular cancer, 2005 - Springer
Cervical cancer remains one of the greatest killers of women worldwide. It is difficult to
foresee a dramatic increase in cure rate even with the most optimal combination of cytotoxic …
foresee a dramatic increase in cure rate even with the most optimal combination of cytotoxic …
Clinical use of circulating nucleosomes
S Holdenrieder, P Stieber - Critical reviews in clinical laboratory …, 2009 - Taylor & Francis
Nucleosomes, complexes of DNA and histone proteins, are released from dying and
stressed cells into the blood circulation. Concentrations of circulating nucleosomes in …
stressed cells into the blood circulation. Concentrations of circulating nucleosomes in …
Circulating histones to detect and monitor the progression of cancer
Liquid biopsies have emerged as a minimally invasive cancer detection and monitoring
method, which could identify cancer-related alterations in nucleosome or histone levels and …
method, which could identify cancer-related alterations in nucleosome or histone levels and …
Circulating nucleosomes as potential biomarkers for cancer diagnosis and treatment monitoring
H Wang, Y Wang, D Zhang, P Li - International Journal of Biological …, 2024 - Elsevier
Nucleosomes play a crucial role in regulating gene expression through their composition
and post-translational modifications. When cells die, intracellular endonucleases are …
and post-translational modifications. When cells die, intracellular endonucleases are …
Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes
Whether nucleic acids that circulate in blood have any patho-physiological functions in the
host have not been explored. We report here that far from being inert molecules, circulating …
host have not been explored. We report here that far from being inert molecules, circulating …
Apoptotic markers in cancer
S Holdenrieder, P Stieber - Clinical Biochemistry, 2004 - Elsevier
In cancer, apoptotic processes occur both spontaneously and induced by antitumor
therapies. Qualitative and quantitative changes in cancer cell death along with proliferative …
therapies. Qualitative and quantitative changes in cancer cell death along with proliferative …